Del Giudice G, Tougne C, Louis J A, Lambert P H, Bianchi E, Bonelli F, Chiappinelli L, Pessi A
Department of Pathology, University of Geneva, Switzerland.
Eur J Immunol. 1990 Jul;20(7):1619-22. doi: 10.1002/eji.1830200733.
The major repetitive epitopes of the surface circumsporozoite (CS) protein of malaria sporozoites represent candidates for the development of subunit vaccines against malaria. However, previous experimental work has shown that repetitive peptides from the CS proteins of Plasmodium falciparum, P. vivax, P. yoelii and P. berghei are immunogenic only in mice with the H-2b or H-2k haplotype. This led to the conclusion that strong T helper epitopes from the non-repetitive CS sequences were required in the design of sporozoite vaccines. In the present study, we investigated the immunogenicity in mice of a octa-branched multiple antigen peptide (MAP) containing repeats of the CS protein of the human malaria parasite, P. malariae, [MAP8(NAAG)6], and found that mice with an H-2b, H-2d, H-2k, H-2f, H-2q, and H-2s haplotype produced anti-peptide antibodies after immunization and that only H-2r mice were nonresponsive. This antibody response, not induced in athymic H-2b nu/nu mice, was directed against the (NAAG) sequence, but not against the lysine core of the MAP construct. Finally, when covalently linked to a synthetic polymer of the repetitive (NANP) sequence of the P. falciparum CS protein, [MAP8(NAAG)6] behaved as a carrier molecule for the production of anti-(NANP)n antibodies in H-2d and H-2k mice, genetically nonresponder to the (NANP)n sequence. Should this wide immunogenicity of the P. malariae CS (NAAG) repetitive sequence also apply to humans, it might be considered for the design of multivalent subunit malaria vaccines.
疟疾子孢子表面环子孢子蛋白(CS)的主要重复表位是开发疟疾亚单位疫苗的候选对象。然而,以往的实验研究表明,恶性疟原虫、间日疟原虫、约氏疟原虫和伯氏疟原虫CS蛋白的重复肽仅在具有H-2b或H-2k单倍型的小鼠中具有免疫原性。由此得出结论,在子孢子疫苗设计中需要来自非重复CS序列的强T辅助表位。在本研究中,我们调查了含有人疟原虫——三日疟原虫CS蛋白重复序列的八分支多抗原肽(MAP)[MAP8(NAAG)6]在小鼠中的免疫原性,发现具有H-2b、H-2d、H-2k、H-2f、H-2q和H-2s单倍型的小鼠在免疫后产生了抗肽抗体,只有H-2r小鼠无反应。这种抗体反应在无胸腺H-2b nu/nu小鼠中未诱导产生,它针对的是(NAAG)序列,而非MAP构建体的赖氨酸核心。最后,当与恶性疟原虫CS蛋白重复(NANP)序列的合成聚合物共价连接时,[MAP8(NAAG)6]在对(NANP)n序列遗传无反应的H-2d和H-2k小鼠中作为产生抗(NANP)n抗体的载体分子。如果三日疟原虫CS(NAAG)重复序列的这种广泛免疫原性也适用于人类,那么它可能会被考虑用于设计多价亚单位疟疾疫苗。